导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.39% | 653/1050 |
| 近一周 | -2.71% | 692/1104 |
| 近一月 | -8.62% | 967/1102 |
| 近一季 | -6.86% | 689/1092 |
| 近半年 | -11.91% | 833/1070 |
| 近一年 | 5.55% | 470/1018 |
| 近两年 | 29.76% | 691/926 |
| 近三年 | 19.53% | 508/833 |
| 成立以来 | 261.44% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.75% 211/1070 |
11.59% 524/1101 |
- - |
- - |
| 2025 | 15.11% 752/1065 |
-3.50% 974/1014 |
-3.11% 900/1038 |
19.55% 621/1050 |
2.97% 244/1065 |
| 2024 | 13.76% 203/1011 |
1.02% 264/960 |
2.40% 177/983 |
12.77% 402/991 |
-2.48% 487/1011 |
| 2023 | -3.05% 161/952 |
6.98% 225/880 |
6.84% 28/895 |
-8.75% 539/915 |
-7.05% 681/952 |
| 2022 | -14.65% 163/867 |
-20.58% 551/773 |
5.17% 512/806 |
-0.26% 17/845 |
2.45% 302/867 |
| 2021 | 34.01% 52/740 |
-1.89% 220/580 |
13.28% 281/659 |
4.73% 128/704 |
15.13% 23/740 |
| 2020 | 62.95% 176/554 |
4.38% 82/419 |
19.29% 298/466 |
16.06% 130/517 |
12.75% 262/554 |
| 2019 | 54.01% 123/410 |
35.02% 144/1149 |
-5.16% 722/1231 |
7.50% 151/390 |
11.88% 113/410 |
| 2018 | -23.18% 120/349 |
- - |
- - |
- - |
-8.32% 170/1080 |
| 2017 | 11.47% 126/285 |
- - |
- - |
- - |
- - |
| 2016 | -24.54% 136/205 |
- - |
- - |
- - |
- - |
| 2015 | 40.37% 36/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 大成产业升级股票(LOF)A VS. 东吴新产业精选股票A(580008) |